| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/25/2005 | US6846653 Amplification of preferential polypeptide in bacteria; obtain cells, transform with vector coding preferential polypetide, express vector, recover polypeptide |
| 01/25/2005 | US6846651 Comprises sequence of influenza bacterial genome and position of proteins relative to specific restriction enzyme; diagnosis and treatment of respiratory disorders; genetic mapping |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846647 Polypeptides suppressing smooth muscle cell proliferation, the encoding cDNA, and related methods |
| 01/25/2005 | US6846487 Therapeutic compositions for treating infection by Lawsonia spp. |
| 01/25/2005 | US6846483 Microbial composition and a process useful for the neutralization of alkaline waste-waters |
| 01/25/2005 | US6846084 Apparatus for using optical tweezers to manipulate materials |
| 01/25/2005 | CA2308292C Method of dna shuffling |
| 01/25/2005 | CA2302873C Nucleic and amino acid sequences for a novel transketolase from (mentha piperita) |
| 01/25/2005 | CA2133108C Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005005773A2 A process for enhanced recovery of crude oil from oil wells using novel microbial consortium |
| 01/20/2005 | WO2005005631A1 Hla-a24 binding cancer antigen peptide derived from ribin |
| 01/20/2005 | WO2005005617A1 Triacylglycerol-deficient fission yeast and its uses |
| 01/20/2005 | WO2005005616A2 Compositions and methods for stable isotope labelling of biological compounds |
| 01/20/2005 | WO2005005613A2 Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein |
| 01/20/2005 | WO2005004908A1 Ultrafiltration for preparing outer membrane vesicles |
| 01/20/2005 | WO2005004639A1 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 01/20/2005 | WO2004101826A3 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi |
| 01/20/2005 | WO2004093909A9 Methods to regulate biofilm formation |
| 01/20/2005 | WO2004076648A9 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 01/20/2005 | WO2004044189A3 Novel purified polypeptides involved in metabolism |
| 01/20/2005 | WO2004015057A3 Mucin-immunoglobulin fusion proteins |
| 01/20/2005 | WO2003076630A8 Method of controlling ethanol production and mass production of lactic acid and transformant therefor |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2001096591A9 Process for producing carotenoid pigments |
| 01/20/2005 | US20050015832 Coding for polyol carriers in plants or fungi in polyols with main chain of 5 to 8 carbons with 6 the ideal such as manniotol |
| 01/20/2005 | US20050014935 Chimeric protein comprising amadoriase activity for use in diagnosis and prognosis of diabetic pathologies |
| 01/20/2005 | US20050014931 A monoclonal antibody or an antigen-binding fragment thereof that specifically binds the capsular polysaccharide of Streptococcus pneumoniae serotype PPS 3; heavy chain amino acid sequence as well as DNA encoding it; complementary determining regions; pneumonia; passive immunizations; diagnosis/medical/ |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014270 Expression vector comprising yarrowia regulatory sequences for use in expression of preferential heterologous nucleotide sequences |
| 01/20/2005 | US20050014262 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 01/20/2005 | US20050014245 Apparatus for lysing cells in a controlled manner so as to efficiently separate insoluble components from a fluid lysate containing cellular components of interest; biopolymer purification |
| 01/20/2005 | US20050014244 Mutant nucleic acid; applying to textiles; animal feeds; genetic engineering |
| 01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
| 01/20/2005 | US20050014240 Non-immunognic polyethylene glycol conjugated therapeutic uricase for use in treatment of kidney and inflammatory disorders |
| 01/20/2005 | US20050014239 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/20/2005 | US20050014238 Glycerol dehydratase for use in catalyzing the fermentation of glycerol to 1,3-propanediol in transgenic microorganism; preparing polyester fibers |
| 01/20/2005 | US20050014236 Method for producing L-arginine or L-lysine by fermentation |
| 01/20/2005 | US20050014235 Nucleotide sequences coding glucose-6-phosphate-dehydrogenase for use in the preparation of amino acids for use in animal feeds, cosmetics and medicines |
| 01/20/2005 | US20050014234 Genes from the corynebacterium glutamicum coding for regulatory proteins |
| 01/20/2005 | US20050014233 DNA, nucleaotides sequences and polynucleotides that code for sugar metabolism and oxidative phosphorylation proteins; genetic engineered microorganisms used for biosynthesis of amino acids |
| 01/20/2005 | US20050014231 Nucleotide sequences coding enzymatic polypeptides associated with synthesis of polyunsaturated fatty acids for use as additives in pharmaceutical and nutritional compositions |
| 01/20/2005 | US20050014229 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014227 Proteases from gram positive organisms |
| 01/20/2005 | US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014219 Genes encoding carotenoid compounds |
| 01/20/2005 | US20050014215 Chromogens; fluorogens; improved sensitivity, translucence, and stability via ready-to-use liquid or gel containing polyethoxylated fatty acid, sorbitan ester and solvent (dimethyl sulfoxide) |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050014152 Drug transporter and use thereof |
| 01/20/2005 | US20050014150 Screening eukaryotic messenger RNA sequences and identifying internal ribosome entry site (IRES) elements for use in cap-independent expression of foreign genes in eukaryotic cells; enhancing in vitro translation heterologous |
| 01/20/2005 | US20050014148 Compositions and methods relating to ovary specific genes and proteins |
| 01/20/2005 | US20050014139 Human cyclin I and genes encoding same |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013808 Nitroreductase enzymes |
| 01/20/2005 | US20050013788 Sorptive composite materials |
| 01/20/2005 | DE10329819A1 Isolating organic compounds from cell cultures, useful for recovering chiral intermediates for pharmaceuticals, includes organic extraction, after incubation with hydrolase to destroy bioemulsifiers |
| 01/20/2005 | CA2532038A1 Compositions and methods for stable isotope labelling of biological compounds |
| 01/20/2005 | CA2531963A1 A process for enhanced recovery of crude oil from oil wells using novel microbial consortium |
| 01/19/2005 | EP1498489A2 Ascorbic acid production from yeasts |
| 01/19/2005 | EP1498484A1 Glucose dehydrogenase beta-subunit and dna encoding the same |
| 01/19/2005 | EP1498481A1 Mutated subtilisin genes |
| 01/19/2005 | EP1498480A2 Human hydrolytic enzymes |
| 01/19/2005 | EP1498476A1 Mutated alkaline cellulase |
| 01/19/2005 | EP1498429A2 Rationally designed antibodies |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498145A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 01/19/2005 | EP1498039A1 Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods |
| 01/19/2005 | EP1497457A1 Method and kit for detecting membrane protein-protein interactions |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497443A2 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria |
| 01/19/2005 | EP1497434A2 Matrix analysis of gene expression in cells (magec) |
| 01/19/2005 | EP1497432A2 Improved bacillus host cell |
| 01/19/2005 | EP1497431A2 Improved bacillus host cell |
| 01/19/2005 | EP1497430A2 Improved bacillus host cell |
| 01/19/2005 | EP1497429A2 Improved bacillus host cell |
| 01/19/2005 | EP1497428A2 Surface transfection and expression procedure |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497416A2 Thermostable dna polymerases and methods of making same |
| 01/19/2005 | EP1497409A2 Growth medium for microorganisms comprising the biomass of methanotrophic bacteria |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497319A2 Cell adhesion and extracellular matrix proteins |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497307A2 Recombinant p.falciparum merozoite protein-1 42 vaccine |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1496737A2 .ce1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 01/19/2005 | EP0862580B1 Streptoccal inhibitor of complement-mediated lysis, protein sic |
| 01/19/2005 | EP0804074B1 Treating red blood cell solutions with anti-viral agents |
| 01/19/2005 | EP0706572B1 Microbial transformants of hansenula that express glycolate oxydase and catalase |
| 01/19/2005 | EP0545946B1 Growth-promoting agent |
| 01/19/2005 | CN1568374A Method for identifying compounds modulating reverse cholesterol transport |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568367A Method for unspecific enrichment of bacterial cells |
| 01/19/2005 | CN1568365A Composition comprising a lactobacillus pentosus strain and uses thereof |